VNO
65
2
NSC
70
17
IR
79
8
HUM
39
4
KEY
74
9
EXPD
39
10
JNPR
60
2
WHR
57
10
HSY
38
-3
AMZN
63
6
LNC
69
7
EXPE
72
10
TEL
71
8
MTB
75
6
PEG
60
2
NEM
56
-5
JCI
60
3
PLD
45
-3
TROW
42
8
CRM
59
7
VNO
65
2
NSC
70
17
IR
79
8
HUM
39
4
KEY
74
9
EXPD
39
10
JNPR
60
2
WHR
57
10
HSY
38
-3
AMZN
63
6
LNC
69
7
EXPE
72
10
TEL
71
8
MTB
75
6
PEG
60
2
NEM
56
-5
JCI
60
3
PLD
45
-3
TROW
42
8
CRM
59
7
Financhill
Back

Exact Sciences Stock Predictions

The key to a $1.3T opportunity

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Buy
55

EXAS
Exact Sciences

Last Price:
$54.39
Seasonality Move:
16.18%

7 Day Trial

ALL ACCESS PASS

$ 7

FREE Copy of "2025 Gold Forecast: A Perfect Storm for Demand"

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report here

Exact Sciences Stock Forecast

  • Over the next 52 weeks, Exact Sciences has on average historically risen by 34.4% based on the past 24 years of stock performance.
  • Exact Sciences has risen higher in 13 of those 24 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.17%
  • Is Exact Sciences Stock Undervalued?
    The current Exact Sciences [EXAS] share price is $53.40. The Score for EXAS is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • EXAS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Exact Sciences Stock Go Up Next Year?

  • Over the next 52 weeks, Exact Sciences has on average historically risen by 34.4% based on the past 24 years of stock performance.

Exact Sciences Stock Rating

Buy
55
Exact Sciences (EXAS) is a Buy

Is Exact Sciences overpriced?

  • Exact Sciences has risen higher in 13 of those 24 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.17%

Exact Sciences Stock Price History

Is EXAS stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EXAS is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
exactsciences.com

52-Week Data

52-Week High:
72.83
52-Week Low:
39.97

Prediction Charts

Market Cap:
10.1B
Price in USD:
53.40
Volume:
1.8M
Beta:
1.20

Technical Analysis

SMA50:
46.02
SMA100:
50.45
SMA200:
55.84
52-Wk Change:
-0.21%

Stock Predictions

  • Is Exact Sciences stock public?
    Yes, Exact Sciences is a publicly traded company.
  • What is the Exact Sciences stock quote today?
    The Exact Sciences stock price is 53.40 USD today.
  • How to buy Exact Sciences stock online?
    You can buy Exact Sciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-23 45.17 44.09 46.07 43.98
Apr-24 44.56 45.60 45.64 44.08
Apr-25 44.78 45.46 45.79 44.50
Apr-28 45.99 45.59 46.47 45.08
Apr-29 45.80 44.79 45.93 44.54
Apr-30 44.46 45.64 45.84 44.17
May-1 45.64 47.16 47.58 45.16
May-2 52.12 51.55 54.71 49.94
May-5 51.30 53.33 54.37 50.72
May-6 53.00 53.99 54.49 52.12
May-7 54.38 53.28 54.38 52.44
May-8 53.89 53.06 53.89 52.28
May-9 52.91 51.63 53.67 51.58
May-12 53.02 53.40 53.86 52.14

Exact Sciences Earnings

Exact Sciences Earnings Report: Per Share Exact Sciences Earnings Q1 Q2 Q3 and Q4 last year and next year.

Exact Sciences Forecast Revenue Growth

Exact Sciences Stock Analysis: Historical quarterly revenues per share for Exact Sciences and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.14 per share, an increase this year of $0.79 per share, and an increase next year of $0.76 per share.

* Exact Sciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.